
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading research institution in Lübeck is seeking a PhD candidate for a project focusing on immune responses at barrier organs. The candidate will conduct innovative research and participate in extensive training programs. Applicants should hold a Master’s in life sciences and have a strong command of English, with additional skills in mouse models and bioinformatics being advantageous. The position is part-time, involving a salary based on the German E13 TV-L scale.
Institute for Inflammation Medicine
TheDFG-funded Research Training Group (RTG) 3095 "Protective and pathogenic antibody responses at barrier organs" is a collaborative doctoral programme jointly organized by the University of Lübeck and Kiel University—two modern and research-intensive universities with strong profiles in medicine, molecular biology, and life sciences. Their study programmes have consistently achieved top rankings in the CHE Ranking, the most comprehensive evaluation of study programmes at German universities.
Immunological barrier organs such as the skin, intestine, and lungs are continuously exposed to commensal microorganisms, pathogens, and environmental allergens. As a result, infections as well as allergic and autoinflammatory disorders at these mucosal interfaces are frequent and represent a significant burden to public health. Antibody-mediated immune responses play a central role in maintaining homeostasis at these sites: they contribute to the control of pathogen invasion, the regulation of gut microbiota, and the initiation and modulation of allergic reactions, while also exerting regulatory functions that can downregulate inflammation.
The overarching goal of RTG 3095 is to elucidate the mechanisms by which B cell responses are initiated, maintained, and contribute to either immunoprotection or immunopathogenesis at these immunological barrier sites. To achieve this, the programme employs state‑of‑the‑art experimental approaches, including single‑cell sequencing, spatial transcriptomics, and advanced molecular and immunological techniques. Doctoral researchers will benefit from a structured 4-year training programme that integrates cutting‑edge research with comprehensive training opportunities.
Within this framework, the subproject P01 "Allergenicity of IgE and IgG1 clonotypes in murine food allergy", led by Prof. Rudolf Manzat at the Institute for Systemic Inflammation Research (ISEF) https://isef-luebeck.de/en/meet-the-lab/manz-lab-3 , University of Lübeck, is seeking a PhD Candidate to start on April 1, 2026. The position is initially limited until March 31, 2030.
Please submit your application until 14th December 2025, indicating the reference number 27550.
Please include the following documents with your application:
Application to this subproject of RTG 3095 is generally considered to be an application also to the other subprojects of RTG 3095. Separate application to another subproject is not required, but please indicate in your motivation letter your preferred RTG 3095 subprojects (see above, motivation letter).
Among the written applications, the most suitable candidates will be invited to a one‑day symposium, which will take place in January 2026 in Lübeck, Germany.
For further information, please contact: